GlassScriptPhysician profile
Marcelle M Owens
NPI 1295785814
$1,834.31
in general payments reported to CMS, 2019-2025
24 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $95.82 · 2021: $297 · 2022: $183 · 2023: $380 · 2024: $320 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $787.78 | 2019-2025 | |
| Genzyme Corporation | $197.05 | 2023-2025 | |
| Janssen Biotech, INC. | $96.52 | 2019-2025 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $87.34 | 2019-2021 | |
| Lilly USA, LLC | $79.15 | 2023-2025 | Omvoh |
| Braintree Laboratories, INC. | $65.91 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $51.80 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.21 | 2020-2022 | |
| Fresenius Kabi USA, LLC | $45.74 | 2023 | Idacio |
| Celgene Corporation | $43.56 | 2023 | Zeposia |
| Medtronic, INC. | $38.96 | 2025 | Interstim |
| Pfizer INC. | $38.41 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $31.80 | 2024 | Dupixent |
| Amgen INC. | $29.17 | 2020 | |
| Alfasigma USA, INC. | $24.15 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $22.54 | 2021 | |
| Nestle Healthcare Nutrition INC. | $22.52 | 2021 | |
| Intercept Pharmaceuticals, INC. | $20.53 | 2023 | Ocaliva |
| Organon LLC | $20.40 | 2025 | Renflexis, Hadlima |
| Mauna Kea Technologies, INC. | $19.91 | 2024 | |
| Qol Medical, LLC | $16.86 | 2021 | |
| Exact Sciences Corporation | $16.64 | 2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $15.00 | 2025 | Voquezna |
| Hologic Sales and Service, LLC | $13.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcelle Owens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.